NEW TREATMENT OPPORTUNITIES FOR POLYCYSTIC OVARY SYNDROME
Keywords:
polycystic ovary syndrome, etiology, treatment, myoinositol, ovulation induction, drills, oral combined contraceptives, life style changesAbstract
Polycystic ovary syndrome (PCOS) is a heterogeneous complex disorder characterized by oligo-anovulation, hyperandrogenism and/or hyperandrogenemia, and polycystic ovarian morphological changes. Interest in PCOS encompasses several specific aspects, including reproductive, cosmetic, and medical aspects
References
Али Р. М. и др. Генетические ассоциации между полиморфными локусов генов ферментов антиоксидантной защиты GPX4 (rs713041), GSTP1 (rs1695) и PON1 (rs662) и синдромом поликистозных яичников у российских женщин //Медицинская генетика. – 2024. – Т. 23. – №. 3. – С. 21-30.;
Dumesic DA, Abbott DH, Chazenbalk GD. An Evolutionary Model for the Ancient Origins of Polycystic Ovary Syndrome. J Clin Med. 2023 Sep 22;12(19):6120. doi: 10.3390/jcm12196120. PMID: 37834765; PMCID: PMC10573644
Гасиева Д. М. и др. Синдром поликистозных яичников: новые и перспективные варианты лечения //Problems of Endocrinology. – 2024. – Т. 70. – №. 4. – С. 103
Joham A.E., Norman R.J., Stener-Victorin E. et al. Polycystic ovary syndrome. Lancet Diabetes Endocrinol. 2022;10(9):668–680. DOI: 10.1016/S2213-8587(22)00163-2.
Unluhizarci K., Karaca Z., Kelestimur F. Role of insulin and insulin resistance in androgen excess disorders. World J Diabetes. 2021;12(5):616–629. DOI: 10.4239/wjd.v12.i5.616.
Moghetti P., Tosi F. Insulin resistance and PCOS: chicken or egg? J Endocrinol Invest. 2021;44(2):233–244. DOI: 10.1007/s40618-020-01351-0.
Kamenov Z., Gateva A. Inositols in PCOS. Molecules. 2020;25(23):5566. DOI: 10.3390/molecules25235566.
Siddiqui S. et al. A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS) //Journal of assisted reproduction and genetics. – 2022. – Т. 39. – №. 11. – С. 2439-2473.;
Рахимов Н. М. и др. ЭФФЕКТИВНОСТЬ ЛЕЧЕНИЯ АСЦИТА ОБУСЛОВЛЕННЫЙ РЕЦИДИВОМ ПЛАТИНОРЕФРАКТЕРНОГО РАКА ЯИЧНИКА С ИСПОЛЬЗОВАНИЕМ МЕТРОНОМНОЙ ХИМИОТЕРАПИИ //ЖУРНАЛ РЕПРОДУКТИВНОГО ЗДОРОВЬЯ И УРО-НЕФРОЛОГИЧЕСКИХ ИССЛЕДОВАНИЙ. – 2024. – Т. 5. – №. 1.
Abdurakhmonov Jurabek , Rahimov Nodir , Shakhanova Shakhnoza . Modern view on ascite in ovarian cancer. Journal of Biomedicine and Practice . 2022, vol . 7, issue 4, pp . 130-139
Alimjanovich JR, Agababyan LR, Kamalov AI Prevention and Treatment of Postpartum Hemorrhage //CENTRAL ASIAN JOURNAL OF MEDICAL AND NATURAL SCIENCES. – 2021. – T. 2. – No. 4. – S. 204-209.
Rizaev Jasur , Rakhimov Nodir , Kodyrov Khamidullo , Shakhanova Shakhnoza . Study of prostate cancer death by regions of the republic of Uzbekistan.Journal of Biomedicine and Practice. 2022, vol . 7, issue 5, pp.202-210
Cаrlomagno G., Unfer V., Roseff S. The D-chirо-inоsitol paradox in the ovary. Fertil Steril. 2011;95(8):2515–2516. DOI: 10.1016/j.fertnstert.2011.05.027.
De Leo V., Musacchio M.C., Cappelli V. et al. Genetic, hormonal and metabоlic aspects of PCOS: an update. Reprod Biol Endocrinol. 2016;14(1):38. DOI: 10.1186/s12958-016-0173-x.
Behboudi-Gandevani S., Ramezani Tehrani F., Rostami Dovom M. et al. Insulin resistance in obesity and polycystic ovary syndrоme: systematic review and meta-analysis of observational studies. Gynecol Endocrinol. 2016;32(5):343–353. DOI: 10.3109/09513590.2015.1117069.
Guarano A., Capоzzi A., Cristodoro M. et al. Alpha Lipoic Acid Efficacy in PCOS Treatment: What Is the Truth? Nutrients. 2023;15(14):3209. DOI: 10.3390/nu15143209.
